We are investigating different formulations of ultra-small nanoparticles that can perform as both image contrast and radiation dose amplification agents. This concept is particularly relevant in the context of MR-guided radiation therapy, an emerging clinical technique. Our partners in France, led by Dr. Olivier Tillement, have demonstrated the safety of these nanoparticles in a Phase 1 clinical trial.
